Ameriprise Financial Inc Rubius Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $73,579 - $556,971	-93,139 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $45,169 - $110,531	10,628 Added 12.88%	93,139 $513,000
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $217,345 - $398,316	22,453 Added 37.39%	82,511 $798,000
Q3 2021 Nov 15, 2021	BUY	$17.6 - $25.91 $119,627 - $176,110	6,797 Added 12.76%	60,058 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $107,693 - $137,544	4,838 Added 9.99%	53,261 $1.3 Million
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $508,315 - $2.03 Million	-63,381 Reduced 56.69%	48,423 $1.28 Million
Q4 2020 Feb 12, 2021	SELL	$4.23 - $8.73 $100,572 - $207,564	-23,776 Reduced 17.54%	111,804 $848,000
Q3 2020 Nov 16, 2020	SELL	$4.65 - $6.25 $395 - $531	-85 Reduced 0.06%	135,580 $680,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $79,041 - $135,611	19,711 Added 17.0%	135,665 $812,000
Q1 2020 May 15, 2020	BUY	$3.74 - $9.84 $5,920 - $15,576	1,583 Added 1.38%	115,954 $517,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $14.12 $208,520 - $407,234	28,841 Added 33.72%	114,371 $1.09 Million
Q3 2019 Nov 14, 2019	SELL	$7.85 - $15.75 $382,145 - $766,725	-48,681 Reduced 36.27%	85,530 $672,000
Q2 2019 Aug 14, 2019	BUY	$13.5 - $19.94 $460,080 - $679,555	34,080 Added 34.04%	134,211 $2.11 Million
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $1.1 Million - $1.54 Million	83,031 Added 485.56%	100,131 $1.81 Million
Q4 2018 Feb 14, 2019	BUY	$13.83 - $22.97 $236,493 - $392,787	17,100 New	17,100 $275,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.